MIT sued over infected mice; miRagen launches PhI scleroderma study;

@FierceBiotech: China's new pharma crackdown may help top companies. Story | Follow @FierceBiotech

@JohnCFierce: Gilead, Sanofi singled out as worst offenders in failing to disclose trial data. More | Follow @JohnCFierce

@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." News | Follow @DamianFierce

> An insurer for the Broad Institute is suing MIT, claiming that it provided mice that infected its labs with pinworms. Story

> Boulder, CO-based miRagen Therapeutics launched a Phase I clinical study of MRG-201, a synthetic microRNA mimic to microRNA-29b. The study starts with healthy volunteers and then may be extended to patients suffering from cutaneous scleroderma. Release

Medical Device News

@FierceMedDev: AliveCor adds former Google exec as CEO to further consumer ECG push. Story | Follow @FierceMedDev

@VarunSaxena2: Boston Sci's Watchman hit by restrictive CMS coverage decision, recall over blood leakage. Article | Follow @VarunSaxena2

@EmilyWFierce: Women are suing Endo Health Solutions and Patheon for child support after contraceptive packaging mishap. More | Follow @EmilyWFierce

> Resurgent 23andMe CEO says the genetic testing company is not up for sale. Article

> Philips to launch pneumonia Dx wearable to prevent child deaths in poorer countries. News

Pharma News

@FiercePharma: #ICYMI yesterday: U.S. judge orders Valeant, Ackman to face insider trading suit. Story | Follow @FiercePharma

@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce

@CarlyHFierce: U.S. judge orders Valeant, Ackman to face insider trading suit. Article | Follow @CarlyHFierce

> Novartis, Roche CEOs see performance-based future, but U.S. isn't ready yet. More

> Valeant employees closely involved with Philidor operations: Reuters. News

CRO News

> Quintiles lends its data-crunching know-how to Apple's ResearchKit. More

> PPD deepens its Japanese focus with new joint venture leadership. Story

> WuXi and Lilly pair up to develop a cardio drug in China. Article

> CRO BioDuro merges with Formex after a private equity takeout. More

> Quintiles founder stepping down as chairman after 33 years. News

Pharma Manufacturing News

> Endo, Patheon sued over unplanned pregnancies tied to contraceptive mishap. Item

> CMO Formex and CRO BioDuro merge operations. More

> Cellular Biomedicine adds facility in China that will help with CAR-T processing. Story

> AmerisourceBergen says quality will be PharMEDium's distinguisher, but acknowledges 'quick diligence' ahead of deal. Report

> Pharma cargo thefts jump with $558,000 average losses reported. News

Pharma Asia News

> India's drug regulator handcuffed by low funding, lack of trained personnel. Story

> Japan's Astellas Pharma gets $727M for ailing dermatology unit as it swings to new areas. More

> WuXi and Eli Lilly in pact on cardio candidate development in China. Article

> Japanese ministry knocks Novartis unit, again, on side effects nondisclosure. News

> Daiichi loses Supreme Court decision on Apotex generic. More

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.